{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:38:42Z","timestamp":1790717922482,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/leu.2016.100","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T06:42:07Z","timestamp":1461739327000},"page":"1993-2001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling"],"prefix":"10.1038","volume":"30","author":[{"given":"C S","family":"Tremblay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F C","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Collett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Saw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S K","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S E","family":"Sonderegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S E","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Alserihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Toribio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M P","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Chircop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P J","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Jane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"key":"BFleu2016100_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009; 10: 147\u2013156.","journal-title":"Lancet Oncol"},{"key":"BFleu2016100_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1182\/blood-2013-03-491092","volume":"122","author":"P Van Vlierberghe","year":"2013","unstructured":"Van Vlierberghe P, Ambesi-Impiombato A, De Keersmaecker K, Hadler M, Paietta E, Tallman MS et al. Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia. Blood 2013; 122: 74\u201382.","journal-title":"Blood"},{"key":"BFleu2016100_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri2232","volume":"8","author":"EV Rothenberg","year":"2008","unstructured":"Rothenberg EV, Moore JE, Yui MA . Launching the T-cell-lineage developmental programme. Nat Rev Immunol 2008; 8: 9\u201321.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2016100_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157\u2013163.","journal-title":"Nature"},{"key":"BFleu2016100_CR5","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","volume":"121","author":"M Neumann","year":"2013","unstructured":"Neumann M, Heesch S, Schlee C, Schwartz S, Gokbuget N, Hoelzer D et al. Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood 2013; 121: 4749\u20134752.","journal-title":"Blood"},{"key":"BFleu2016100_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00109-009-0587-4","volume":"88","author":"AC Durieux","year":"2010","unstructured":"Durieux AC, Prudhon B, Guicheney P, Bitoun M . Dynamin 2 and human diseases. J Mol Med (Berl) 2010; 88: 339\u2013350.","journal-title":"J Mol Med (Berl)"},{"key":"BFleu2016100_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ejhg.2012.226","volume":"21","author":"OS Koutsopoulos","year":"2013","unstructured":"Koutsopoulos OS, Kretz C, Weller CM, Roux A, Mojzisova H, Bohm J et al. Dynamin 2 homozygous mutation in humans with a lethal congenital syndrome. Eur J Hum Genet 2013; 21: 637\u2013642.","journal-title":"Eur J Hum Genet"},{"key":"BFleu2016100_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nature10369","volume":"477","author":"K Faelber","year":"2011","unstructured":"Faelber K, Posor Y, Gao S, Held M, Roske Y, Schulze D et al. Crystal structure of nucleotide-free dynamin. Nature 2011; 477: 556\u2013560.","journal-title":"Nature"},{"key":"BFleu2016100_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrm2748","volume":"10","author":"A Sorkin","year":"2009","unstructured":"Sorkin A, von Zastrow M . Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 2009; 10: 609\u2013622.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFleu2016100_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3109\/08977194.2012.683189","volume":"30","author":"RB Luwor","year":"2012","unstructured":"Luwor RB, Chin X, McGeachie AB, Robinson PJ, Zhu HJ . Dynamin II function is required for EGF-mediated Stat3 activation but not Erk1\/2 phosphorylation. Growth Factors 2012; 30: 220\u2013229.","journal-title":"Growth Factors"},{"key":"BFleu2016100_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.devcel.2012.04.005","volume":"22","author":"L Meloty-Kapella","year":"2012","unstructured":"Meloty-Kapella L, Shergill B, Kuon J, Botvinick E, Weinmaster G . Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin. Dev Cell 2012; 22: 1299\u20131312.","journal-title":"Dev Cell"},{"key":"BFleu2016100_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1083\/jcb.200609014","volume":"176","author":"JT Nichols","year":"2007","unstructured":"Nichols JT, Miyamoto A, Olsen SL, D'Souza B, Yao C, Weinmaster G . DSL ligand endocytosis physically dissociates Notch1 heterodimers before activating proteolysis can occur. J Cell Biol 2007; 176: 445\u2013458.","journal-title":"J Cell Biol"},{"key":"BFleu2016100_CR13","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1182\/blood-2009-10-246876","volume":"115","author":"CM Henriques","year":"2010","unstructured":"Henriques CM, Rino J, Nibbs RJ, Graham GJ, Barata JT . IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells. Blood 2010; 115: 3269\u20133277.","journal-title":"Blood"},{"key":"BFleu2016100_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","volume":"1","author":"AA Ferrando","year":"2002","unstructured":"Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75\u201387.","journal-title":"Cancer Cell"},{"key":"BFleu2016100_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood-2004-10-3900","volume":"106","author":"J Soulier","year":"2005","unstructured":"Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombret H et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005; 106: 274\u2013286.","journal-title":"Blood"},{"key":"BFleu2016100_CR16","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1182\/blood-2006-04-019927","volume":"108","author":"P Van Vlierberghe","year":"2006","unstructured":"Van Vlierberghe P, van Grotel M, Beverloo HB, Lee C, Helgason T, Buijs-Gladdines J et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 2006; 108: 3520\u20133529.","journal-title":"Blood"},{"key":"BFleu2016100_CR17","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/sj.leu.2405063","volume":"22","author":"P Van Vlierberghe","year":"2008","unstructured":"Van Vlierberghe P, Beverloo HB, Buijs-Gladdines J, van Wering ER, Horstmann M, Pieters R et al. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia. Leukemia 2008; 22: 1434\u20131437.","journal-title":"Leukemia"},{"key":"BFleu2016100_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","volume":"19","author":"I Homminga","year":"2011","unstructured":"Homminga I, Pieters R, Langerak AW, de Rooi JJ, Stubbs A, Verstegen M et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 2011; 19: 484\u2013497.","journal-title":"Cancer Cell"},{"key":"BFleu2016100_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3324\/haematol.2011.051722","volume":"97","author":"I Homminga","year":"2012","unstructured":"Homminga I, Vuerhard MJ, Langerak AW, Buijs-Gladdines J, Pieters R, Meijerink JP . Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements. Haematologica 2012; 97: 258\u2013261.","journal-title":"Haematologica"},{"key":"BFleu2016100_CR20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1101\/gad.1897910","volume":"24","author":"M Tremblay","year":"2010","unstructured":"Tremblay M, Tremblay CS, Herblot S, Aplan PD, Hebert J, Perreault C et al. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev 2010; 24: 1093\u20131105.","journal-title":"Genes Dev"},{"key":"BFleu2016100_CR21","doi-asserted-by":"publisher","first-page":"e85883","DOI":"10.1371\/journal.pone.0085883","volume":"9","author":"S Smith","year":"2014","unstructured":"Smith S, Tripathi R, Goodings C, Cleveland S, Mathias E, Hardaway JA et al. LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways. PLoS One 2014; 9: e85883.","journal-title":"PLoS One"},{"key":"BFleu2016100_CR22","first-page":"3675","volume":"9","author":"RC Larson","year":"1994","unstructured":"Larson RC, Fisch P, Larson TA, Lavenir I, Langford T, King G et al. T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene 1994; 9: 3675\u20133681.","journal-title":"Oncogene"},{"key":"BFleu2016100_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1126\/science.1182378","volume":"327","author":"MP McCormack","year":"2010","unstructured":"McCormack MP, Young LF, Vasudevan S, de Graaf CA, Codrington R, Rabbitts TH et al. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 2010; 327: 879\u2013883.","journal-title":"Science"},{"key":"BFleu2016100_CR24","doi-asserted-by":"publisher","first-page":"8736","DOI":"10.1073\/pnas.87.22.8736","volume":"87","author":"SJ Szilvassy","year":"1990","unstructured":"Szilvassy SJ, Humphries RK, Lansdorp PM, Eaves AC, Eaves CJ . Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc Natl Acad Sci USA 1990; 87: 8736\u20138740.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2016100_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/77819","volume":"1","author":"S Herblot","year":"2000","unstructured":"Herblot S, Steff AM, Hugo P, Aplan PD, Hoang T . SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression. Nat Immunol 2000; 1: 138\u2013144.","journal-title":"Nat Immunol"},{"key":"BFleu2016100_CR26","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.18632\/oncotarget.2218","volume":"6","author":"M Neumann","year":"2015","unstructured":"Neumann M, Vosberg S, Schlee C, Heesch S, Schwartz S, Gokbuget N et al. Mutational spectrum of adult T-ALL. Oncotarget 2015; 6: 2754\u20132766.","journal-title":"Oncotarget"},{"key":"BFleu2016100_CR27","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1182\/blood-2008-08-172841","volume":"113","author":"G Rank","year":"2009","unstructured":"Rank G, Sutton R, Marshall V, Lundie RJ, Caddy J, Romeo T et al. Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant. Blood 2009; 113: 3352\u20133362.","journal-title":"Blood"},{"key":"BFleu2016100_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.devcel.2009.11.005","volume":"17","author":"SM Ferguson","year":"2009","unstructured":"Ferguson SM, Raimondi A, Paradise S, Shen H, Mesaki K, Ferguson et al. Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits. Dev Cell 2009; 17: 811\u2013822.","journal-title":"Dev Cell"},{"key":"BFleu2016100_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1083\/jcb.127.4.915","volume":"127","author":"H Damke","year":"1994","unstructured":"Damke H, Baba T, Warnock DE, Schmid SL . Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J Cell Biol 1994; 127: 915\u2013934.","journal-title":"J Cell Biol"},{"key":"BFleu2016100_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/stem.1345","volume":"31","author":"SM Cleveland","year":"2013","unstructured":"Cleveland SM, Smith S, Tripathi R, Mathias EM, Goodings C, Elliott N et al. Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia. Stem Cells 2013; 31: 882\u2013894.","journal-title":"Stem Cells"},{"key":"BFleu2016100_CR31","doi-asserted-by":"publisher","first-page":"e1004768","DOI":"10.1371\/journal.pgen.1004768","volume":"10","author":"B Gerby","year":"2014","unstructured":"Gerby B, Tremblay CS, Tremblay M, Rojas-Sutterlin S, Herblot S, Hebert J et al. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells. PLoS Genet 2014; 10: e1004768.","journal-title":"PLoS Genet"},{"key":"BFleu2016100_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/intimm\/dxq020","volume":"22","author":"TK Teague","year":"2010","unstructured":"Teague TK, Tan C, Marino JH, Davis BK, Taylor AA, Huey RW et al. CD28 expression redefines thymocyte development during the pre-T to DP transition. Int Immunol 2010; 22: 387\u2013397.","journal-title":"Int Immunol"},{"key":"BFleu2016100_CR33","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1021\/jm900036m","volume":"52","author":"TA Hill","year":"2009","unstructured":"Hill TA, Gordon CP, McGeachie AB, Venn-Brown B, Odell LR, Chau N et al. Inhibition of dynamin mediated endocytosis by the dynoles\u2014synthesis and functional activity of a family of indoles. J Med Chem 2009; 52: 3762\u20133773.","journal-title":"J Med Chem"},{"key":"BFleu2016100_CR34","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nprot.2014.046","volume":"9","author":"MJ Robertson","year":"2014","unstructured":"Robertson MJ, Deane FM, Robinson PJ, McCluskey A . Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase. Nat Protoc 2014; 9: 851\u2013870.","journal-title":"Nat Protoc"},{"key":"BFleu2016100_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1101\/SQB.1995.060.01.027","volume":"60","author":"T Baba","year":"1995","unstructured":"Baba T, Damke H, Hinshaw JE, Ikeda K, Schmid SL, Warnock DE . Role of dynamin in clathrin-coated vesicle formation. Cold Spring Harbor Symp Quant Biol 1995; 60: 235\u2013242.","journal-title":"Cold Spring Harbor Symp Quant Biol"},{"key":"BFleu2016100_CR36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1083\/jcb.150.5.1137","volume":"150","author":"S Sever","year":"2000","unstructured":"Sever S, Damke H, Schmid SL . Dynamin:GTP controls the formation of constricted coated pits, the rate limiting step in clathrin-mediated endocytosis. J Cell Biol 2000; 150: 1137\u20131148.","journal-title":"J Cell Biol"},{"key":"BFleu2016100_CR37","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1091\/mbc.12.9.2578","volume":"12","author":"H Damke","year":"2001","unstructured":"Damke H, Binns DD, Ueda H, Schmid SL, Baba T . Dynamin GTPase domain mutants block endocytic vesicle formation at morphologically distinct stages. Mol Biol Cell 2001; 12: 2578\u20132589.","journal-title":"Mol Biol Cell"},{"key":"BFleu2016100_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/sj.emboj.7601491","volume":"26","author":"R Ramachandran","year":"2007","unstructured":"Ramachandran R, Surka M, Chappie JS, Fowler DM, Foss TR, Song BD et al. The dynamin middle domain is critical for tetramerization and higher-order self-assembly. EMBO J 2007; 26: 559\u2013566.","journal-title":"EMBO J"},{"key":"BFleu2016100_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cellimm.2008.01.002","volume":"250","author":"CJ Van de Wiele","year":"2007","unstructured":"Van de Wiele CJ, Marino JH, Tan C, Kneale HA, Weber J, Morelli JN et al. Impaired thymopoiesis in interleukin-7 receptor transgenic mice is not corrected by Bcl-2. Cell Immunol 2007; 250: 31\u201339.","journal-title":"Cell Immunol"},{"key":"BFleu2016100_CR40","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1158\/0008-5472.CAN-10-3606","volume":"71","author":"A Silva","year":"2011","unstructured":"Silva A, Laranjeira AB, Martins LR, Cardoso BA, Demengeot J, Yunes JA et al. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias. Cancer Res 2011; 71: 4780\u20134789.","journal-title":"Cancer Res"},{"key":"BFleu2016100_CR41","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1182\/blood-2014-07-587857","volume":"125","author":"M Bender","year":"2015","unstructured":"Bender M, Giannini S, Grozovsky R, Jonsson T, Christensen H, Pluthero FG et al. Dynamin 2-dependent endocytosis is required for normal megakaryocyte development in mice. Blood 2015; 125: 1014\u20131024.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2016100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016100","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:11:30Z","timestamp":1648743090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2016100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFleu2016100"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.100","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]},"assertion":[{"value":"24 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}